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Abstract:
Association between opiate use and bladder cancer incidence in Kerman
province in years 1393-1394 and estimation of the economic burden of
bladder cancer in Iran
Background: bladder cancer is the fifth most common cancer in Iran. Recent
studies have proposed opiate use as a probable risk factor for bladder cancer
incidence. Kerman province is a high risk area for opiate use and bladder cancer
incidence. This study has two main parts. In the first parl, we did a validation
study to evaluate opiate use underreporting bias and its sensitivity and
considering the results of our validation study, we designed a case-control study
to investigate the association between opiate use and bladder cancer incidence.
Also u,e calculated population attributable risk fraction for opiate use incidence
and otlier important bladder cancer risk factors. In the second parl we calculated
prevalence and economic burden of bladder cancer and opiate attributed
economic burden for bladder cancer.
\Iethod: first part of the current study consisted of two stages including
".,.i.tion study and case-control study. In validation study, we calculated
--.:s.:-,+ of self-report opiate use in 186 healthy and 178 patient individuals
*s,:: 
-:,re iests. In our case-control study we individually matched age and sex
:. 
-:,,,S .as.s n;ih 616 neighborhood control and compared their opiate use
historl" and other risk factors. In order to validate the result of our case-control
study we did sensitivity analyses. Also we calculated population attributable risk
fraction for opiate use incidence and other important bladder cancer risk factors.
In the second part we used prevalence approach to calculate economic burden of
bladder cancer in Iran. In this part we estimated 5-year prevalence of different
stages of bladder cancer using a Markov model. Using Iranian clinical practice
guideline, we estimated economic burden of bladder cancer in Iran for the vear
1394 according to public and private sector tariffs.
Result: according to validation study result, reported prevalence of opiate use in
patient individuals was significantly more than healthy individuals (36.5 percent
versus 19.3 percent) but the sensitivity of self-report opiate use was not
significantll' different (77.5 percent versus 68.8 percent). According to case-
control studl' result. odds ratio of bladder cancer in low and high consumption
group rvas 3.2(2-5.1) and 4.3(2.7-6.7) respectively. Also route of opiurn use was
not different si-enificantly in two groups. Estimated Population attributable risk
of opiate use considerin-q crude and corrected odds ratio for underreporting in
Iran u'as between 0. 3 3 (0.3 0-0.40) ro 0. 1 B(0 .1 2-0.2.3 ) respectively.
ri ::e second part of our study, the estimated incident and S-year prevalence
:---::e: ci bladder cancer in year 1394 was 5907 and 206g6. Estinated
;.::.::i" :,urden of bladder cancer in Iran was I ,741,340 and2,553,213 million
R-.- :cc,,'rains to public and private sector tariffs. About 40 percent of direct
Fmedical cost of bladder cancer was attributed to recurrent
costs' If we can reduce opiate use consumption to zero,
bladder cancer will decrease about 1g percent in Iran.
cases and fallow up
economic burden of
conclusion: opiate use could be an important risk factor for bladder cancer
incidence' Adjusting for important confounders and biases like temporality,
underreporting and selection bias, we validated the association between opiate
use and incidence of bladder cancer. opiate use is the most important
preventable risk factor for bladder cancer incidence.
Bladder cancer is a costly cancer and its economic burden is considerable.
Diagnosis of patients in early stages, strict fallow up and early detection of
recurrent cases can reduce the cost of treatment and fallow up of these patients.
Controlling important risk factor of bladder cancer including opiate and smoking
will considerably reduce incidence rate and economic burden of bladder cancer.
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